SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-135874
Filing Date
2020-12-15
Accepted
2020-12-15 19:23:56
Documents
1
Period of Report
2020-12-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2038482-1_3.html 3  
1 OWNERSHIP DOCUMENT tm2038482-1_3.xml 3 7634
  Complete submission text file 0001104659-20-135874.txt   9190
Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address
Lamstein Joshua R (Reporting) CIK: 0001665280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39788 | Film No.: 201390866

Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Issuer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations